TAIWAN · TWSE / TPEx
TCI GENE
大江基因 · 6879 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$36.201 month +1.1% · 1 year -11.7%
Directors and supervisors hold15,893,69260.1% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold16,625,69262.8% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 大江生醫股份有限公司 | Chairman · Director · Major shareholder (10%+) | 11,173,692 | 11,173,692 | 42.23% | — | — |
| 林詠翔 | Chairman (corporate representative) · Major shareholder (10%+) | — | 732,000 | 2.77% | — | 5,312,828 |
| 陳敬亭 | Director (corporate representative) · President | — | 50,000 | 0.19% | — | — |
| COUNDE O'YANG | Director (corporate representative) | — | 0 | — | — | — |
| 佳世達科技股份有限公司 | Director · Major shareholder (10%+) | 4,720,000 | 4,720,000 | 17.84% | — | — |
| 楊宏培 | Director (corporate representative) | — | 0 | — | — | — |
| 林水永 | Independent director | — | 0 | — | — | — |
| 孫維新 | Independent director | — | 0 | — | — | — |
| 張可盈 | Independent director | — | 0 | — | — | — |
| 林竣緯 | Chief accountant | — | 0 | — | — | — |